CTOR

Citius Oncology
$0.56
−$0.01 (−1.07%)Jul 27, 2026
0.1PoorMoatMint rating

MoatMint rates Citius Oncology (CTOR) 0.1 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.2 out of 10.

Key metrics

The numbers that frame CTOR today
Market cap
$51.70M
P/E (TTM)
-1.2
EV / FCF
-2.4
Gross margin
80.1%
EV / Sales
9.4
ROIC
-83.9%
Div yield
0%
Debt / equity
0.1
52wk Low
$0.49
52wk High
$2.38

CTOR stock rating

How CTOR scores on quality, value, growth, momentum and financial health
0.1out of 10
Low overallNeutral business, expensive priceTop 99% of ~5,000 US stocks
QualityPoor1.2/10
GrowthPoor0.3/10
MomentumPoor1.3/10
ValuePoor0.7/10
Financial HealthPoor1.2/10

Growth

Revenue and earnings trend for CTOR
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CTOR
Is Citius Oncology a good buy?
No. Citius Oncology has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Citius Oncology is selling at a very high price.
What is the market capitalization of CTOR?
Citius Oncology's market capitalization is $51.70M.
What is the P/E ratio for CTOR stock?
Citius Oncology's current P/E ratio is -1.2.
What is the 52-week high for CTOR stock?
The 52-week high for Citius Oncology is $2.38. The current close of $0.56 is 76.6% below that high.
What is the 52-week low for CTOR stock?
The 52-week low for Citius Oncology is $0.49. The current close of $0.56 is 13.2% above that low.
Does CTOR stock pay dividends?
Citius Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTOR?
Citius Oncology's Debt / Equity ratio is 0.11.